Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.Thrombosis and Haemostasis|January 25, 2008
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized studyDominick J Angiolillo, Esther Bernardo, Jorge Palazuelos, et al.Thrombosis and Haemostasis|July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigationAntonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 6, 2015
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratoryJoshua M Stolker, Michael J Lim, David M Shavelle, et al.The Science of the Total Environment|December 14, 2022
Commuter's personal exposure to air pollutants after the implementation of a cable car for public transport: Results of the natural experiment TrUSTRicardo Morales-Betancourt, Maria A Wilches-Mogollon, Olga L Sarmiento, et al.Journal of Thrombosis and Thrombolysis|November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigationJosé L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.Journal of Thrombosis and Thrombolysis|November 13, 2012
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitusAntonio Tello-Montoliu, Jose Luis Ferreiro, Murali K Kodali, et al.Thrombosis and Haemostasis|December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled studyFrancesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.Pageof 6